FDA Warning Hits Triad Over Sterility Concerns

Drug Industry Daily
A A
An FDA warning letter is pushing a nuclear medicine company to step up its sterility compliance efforts following a poor inspection.

To View This Article:

Login

Subscribe To Drug Industry Daily